https://www.ascenion.de/technologieangebote/functional-ifn-gamma-memory-in-cd4-t-cells-method-for-improved-t-cell-therapy-and-disease-monitoring-in-autoimmune-diseases 2019-07-26T11:13:05+02:00 0.5 https://www.ascenion.de/technologieangebote/bispecific-antibodies-for-cell-type-specific-tnf-inhibition 2019-07-26T11:13:06+02:00 0.5 https://www.ascenion.de/technologieangebote/cell-wall-less-bacteria-l-forms-for-high-yield-heterologous-protein-expression 2019-07-29T10:40:42+02:00 0.5 https://www.ascenion.de/technologieangebote/madl-monoclonal-antibody-a-novel-highly-specific-and-sensitive-biomarker-for-adenocarcinomas-of-the-lung 2019-07-29T10:44:10+02:00 0.5 https://www.ascenion.de/technologieangebote/man6p-specific-single-chain-antibody-fragment-for-detection-of-mucolipidosis-and-optimization-of-enzyme-production-for-ert 2019-07-29T10:44:10+02:00 0.5 https://www.ascenion.de/technologieangebote/human-voxel-models 2019-07-29T10:44:10+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-thr4-p 2019-08-01T10:42:21+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-tyr1-p 2019-08-01T10:42:28+02:00 0.5 https://www.ascenion.de/technologieangebote/tcr 2019-08-01T10:42:45+02:00 0.5 https://www.ascenion.de/technologieangebote/h2bub1-histone2b-ubiquintylated 2019-08-03T01:39:52+02:00 0.5 https://www.ascenion.de/technologieangebote/calcitonin 2019-08-04T22:41:54+02:00 0.5 https://www.ascenion.de/technologieangebote/targeting-of-autoantibodies-to-the-alpha1-adrenergic-receptor-and-the-beta2-adrenergic-receptor-in-alzheimers-and-vascular-dementia 2019-08-05T09:42:04+02:00 0.5 https://www.ascenion.de/technologieangebote/quiescent-b-cells-for-immune-suppression-in-gene-therapy 2019-08-05T09:46:49+02:00 0.5 https://www.ascenion.de/technologieangebote/parp1-mice-an-animal-model-for-cancer-autoimmune-encephalomyelitis-arthritis-and-diabetes 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/gfp-transgenic-zebrafish-strain-as-tool-for-studying-kidney-development 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c3bircg-il10tm1cgn-d3mit11-d3mit19lt 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c3bir129p2b6-il10tm1cgnlt 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/stock-il2rgtm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcg-il10tm1cgndvsj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcg-il10tm1cgn-il4tm1cgndvsj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c3bir129p2b6-il10tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c129p2b6-il10tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129p2-ncam1tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129p2-il4tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129p2-il10tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b10129p2b6-il10tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/129-il10tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/stock-mttptm2sgy-ldlrtm1her-apobtm2sgy-tgmx1-cre1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcg-selltm1tft-itgb7tm1cgnltj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodb6-itgb7tm1cgn2lt 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c57bl6-itgb7tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcajcg-igh-6tm1cgn-tgigh-vb1-8igh-62mjskfswj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcajcg-igh-6tm1cgn-tgigh-vb1-8igh-6m1mjskfswj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nod129s2b6-igh-6tm1cgndoij 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nod129p2b6-il4tm1cgndvsj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129p2-lyzstm1creifoj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c129p2-cd19tm1crecgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/nodcg-igh-6tm1cgn-tgighelmd44ccgdvs 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c57bl6-igk-ctm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/c129p2b6-igh-5tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129s2-igll1tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129s2-igh-6tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6129p2-igh-jtm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b10129s2b6-igh-6tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/129-igh-5tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/129-cd5tm1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/stock-tgbalancer23cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/stock-tgbalancer12cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/stock-tgmx1-cre1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/balbc-tgcmv-cre1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/b6cg-tgmx1-cre1cgnj 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/tenascin-r-knock-out-mice 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/chl1-mice-a-model-for-studying-the-function-of-the-close-homologue-of-adhesion-molecule-l1 2019-08-19T13:58:22+02:00 0.5 https://www.ascenion.de/technologieangebote/mag-mice-a-model-for-studying-pathological-mechanisms-of-acquired-demyelinating-diseases 2019-11-21T09:36:39+01:00 0.5 https://www.ascenion.de/technologieangebote/innovative-plasmids-and-cells-for-sars-cov-2-specific-research 2020-05-14T12:17:12+02:00 0.5 https://www.ascenion.de/technologieangebote/c129s2-igh-6tm1cgnj 2021-04-27T09:41:51+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-treatment-of-dementia-associated-tauopathies 2021-04-28T08:47:37+02:00 0.5 https://www.ascenion.de/technologieangebote/blood-transfusion-safety-system-cairos 2021-05-26T11:06:16+02:00 0.5 https://www.ascenion.de/technologieangebote/treating-c9orf72-alsftd-with-active-vaccination 2021-06-11T08:24:06+02:00 0.5 https://www.ascenion.de/technologieangebote/new-class-of-bacterial-capsule-polymerases-for-cost-effective-synthesis-of-glycoconjugate-vaccines 2021-10-12T12:27:52+02:00 0.5 https://www.ascenion.de/technologieangebote/microrna-125b-5p-a-new-treatment-option-for-drug-induced-acute-liver-failure 2022-03-03T13:54:59+01:00 0.5 https://www.ascenion.de/technologieangebote/contactin1-mousechicken-mouse-monoclonal 2022-07-06T08:21:36+02:00 0.5 https://www.ascenion.de/technologieangebote/hla-dr-specific-gd-t-cell-receptor-to-treat-proliferative-disorders-of-hla-dr-cells 2022-09-14T15:59:41+02:00 0.5 https://www.ascenion.de/technologieangebote/epigenetic-detection-of-early-stage-non-small-cell-lung-cancer-in-blood 2022-09-15T11:27:32+02:00 0.5 https://www.ascenion.de/technologieangebote/flow-cytometric-basophil-activation-test-for-automated-high-throughput-allergy-diagnostics 2022-09-15T11:50:41+02:00 0.5 https://www.ascenion.de/technologieangebote/targeting-host-lipid-homeostasis-to-augment-anti-mycobacterial-treatment 2022-09-15T12:48:46+02:00 0.5 https://www.ascenion.de/technologieangebote/a-fret-based-method-to-measure-seeding-activity-of-misfolded-protein-species-in-complex-biological-samples 2022-10-10T09:55:16+02:00 0.5 https://www.ascenion.de/technologieangebote/non-integrating-alpharetrovirus-based-vector-particles-for-efficient-rna-delivery-and-targeted-gene-modification 2023-02-13T14:15:35+01:00 0.5 https://www.ascenion.de/technologieangebote/non-invasive-pressure-gradient-prediction-for-a-cardiovascular-narrowing 2023-03-22T09:36:21+01:00 0.5 https://www.ascenion.de/technologieangebote/non-invasive-measurement-of-myocardial-power 2023-03-22T09:38:37+01:00 0.5 https://www.ascenion.de/technologieangebote/nmdar-targeted-caar-t-cell-therapy 2023-04-17T10:10:45+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-tph-inhibitors-for-the-treatment-of-fibrotic-diseases-and-pulmonary-arterial-hypertension-pah 2023-05-19T11:13:36+02:00 0.5 https://www.ascenion.de/technologieangebote/crispr-switch-inducible-sgrna-expression-for-tightly-regulated-efficient-and-safer-crisprcas9-genome-editing 2023-05-24T09:32:12+02:00 0.5 https://www.ascenion.de/technologieangebote/spacer-nick-genome-editing-of-hematopoietic-stem-and-progenitor-cells-and-t-cells 2023-06-13T15:28:38+02:00 0.5 https://www.ascenion.de/technologieangebote/predicting-the-therapeutic-effect-of-compositions-containing-bh3-mimetics 2023-06-26T15:20:45+02:00 0.5 https://www.ascenion.de/technologieangebote/triggering-of-plant-immunity-through-bacterial-hydroxy-fatty-acid-metabolites 2023-07-14T08:47:55+02:00 0.5 https://www.ascenion.de/technologieangebote/rapid-quantitation-of-virus-neutralizing-antibodies-in-biosamples-a-novel-bsl1-approach-based-on-virus-like-particles-vlps 2023-07-14T09:31:34+02:00 0.5 https://www.ascenion.de/technologieangebote/blood-based-tuberculosis-precision-medicine-transcriptomic-model-shortens-therapy-duration 2023-07-14T09:37:43+02:00 0.5 https://www.ascenion.de/technologieangebote/method-for-high-yield-production-of-megakaryocytes 2023-07-14T09:45:35+02:00 0.5 https://www.ascenion.de/technologieangebote/multiplextrode-a-completely-novel-electrode-for-analogue-multiplexing 2023-07-14T09:50:28+02:00 0.5 https://www.ascenion.de/technologieangebote/herv-inhibitors-for-use-in-tauopathies 2023-07-14T09:51:53+02:00 0.5 https://www.ascenion.de/technologieangebote/liver-stem-cell-generation-for-therapeutic-applications 2023-08-16T09:00:19+02:00 0.5 https://www.ascenion.de/technologieangebote/autofocus-control-of-a-microscope-including-an-electrically-tunable-lens 2023-08-18T10:19:41+02:00 0.5 https://www.ascenion.de/technologieangebote/ex-vivo-method-for-determination-of-oxidative-stress-and-diagnosis-of-ferroptosis-associated-diseases 2023-09-04T16:48:19+02:00 0.5 https://www.ascenion.de/technologieangebote/microelectrode-array-with-combined-optical-stimulation 2023-10-05T12:03:10+02:00 0.5 https://www.ascenion.de/technologieangebote/keratinophile-photosensitizers-for-safe-and-rapid-treatment-of-onychomycosis 2023-10-09T09:26:30+02:00 0.5 https://www.ascenion.de/technologieangebote/expansion-of-pancreatic-progenitors-derived-from-human-pluripotent-stem-cells-und-gmp-compliant-conditions 2023-10-09T12:14:25+02:00 0.5 https://www.ascenion.de/technologieangebote/sarseq-multiplexed-parallel-detection-of-sars-cov2-variants-and-other-viruses-in-high-throughput 2023-10-09T17:40:16+02:00 0.5 https://www.ascenion.de/technologieangebote/drug-combinations-to-overcome-therapy-resistance-in-cancer 2023-11-16T10:25:28+01:00 0.5 https://www.ascenion.de/technologieangebote/next-generation-allogeneic-car-nk-cell-platform-for-treatment-of-malignant-diseases 2023-12-22T14:12:19+01:00 0.5 https://www.ascenion.de/technologieangebote/micenbspwith-kidney-specific-megalin-gene-defect 2024-01-24T15:41:27+01:00 0.5 https://www.ascenion.de/technologieangebote/kinin-b1-receptor-knock-out-mice 2024-01-24T15:42:11+01:00 0.5 https://www.ascenion.de/technologieangebote/tryptophan-hydroxylase-1-knockout-mice-as-a-tool-to-study-the-function-of-serotonin 2024-01-24T15:43:26+01:00 0.5 https://www.ascenion.de/technologieangebote/double-transgenic-rats-as-a-tool-to-study-the-function-of-the-renin-angiotensin-system 2024-01-24T15:44:05+01:00 0.5 https://www.ascenion.de/technologieangebote/tgrhklk1-transgenic-rats-as-a-tool-to-study-the-kallikrein-kinin-system 2024-01-24T15:44:58+01:00 0.5 https://www.ascenion.de/technologieangebote/angiotensinogen-transgenic-mice-tgmraogen123 2024-01-24T15:45:32+01:00 0.5 https://www.ascenion.de/technologieangebote/renin-transgenic-rat-tgrmren227 2024-01-24T15:47:20+01:00 0.5 https://www.ascenion.de/technologieangebote/conductin-lacz-mice-as-a-model-for-wnt-mediated-tumorigenesis 2024-01-24T15:52:01+01:00 0.5 https://www.ascenion.de/technologieangebote/ccr7-mice-a-model-for-studies-on-early-immune-reponses-towards-alloantigens 2024-01-24T15:52:30+01:00 0.5 https://www.ascenion.de/technologieangebote/slp3-mutant-mice-an-animal-model-lacking-touch-evoked-neuropathic-pain 2024-01-24T15:52:59+01:00 0.5 https://www.ascenion.de/technologieangebote/animal-model-for-endotoxic-shock-transgenic-rats-with-endothelial-overexpression-of-kinin-b1-receptors 2024-01-24T15:53:38+01:00 0.5 https://www.ascenion.de/technologieangebote/time-efficient-assessment-of-pulmonary-function-via-ct-with-low-radiation-doses 2024-02-12T13:49:47+01:00 0.5 https://www.ascenion.de/technologieangebote/tcr-agnostic-identification-of-tumor-specific-t-cells-for-cancer-diagnostics-and-therapy 2024-03-01T11:26:00+01:00 0.5 https://www.ascenion.de/technologieangebote/vinpocetine-inhibiting-pde1-a-target-for-disease-modifying-therapy-of-synucleinopathies-like-multiple-system-atrophy-msa 2024-04-24T11:18:50+02:00 0.5 https://www.ascenion.de/technologieangebote/crisprgold-design-of-efficient-crisprcas-sgrna-sequences-and-off-target-prediction 2024-05-13T16:31:04+02:00 0.5 https://www.ascenion.de/technologieangebote/replacement-of-allergen-challenge-safely-scoring-prevalence-amp-severity-of-allergies 2024-07-26T10:12:36+02:00 0.5 https://www.ascenion.de/technologieangebote/diagnostic-assay-for-determination-of-personal-microbial-metabolite-production-profile-for-nutritional-adjustment 2024-08-21T09:10:25+02:00 0.5 https://www.ascenion.de/technologieangebote/rapid-simultaneous-and-non-destructive-blood-diagnostics-using-a-multi-omics-nmr-platform 2024-10-14T11:48:10+02:00 0.5 https://www.ascenion.de/technologieangebote/automated-production-of-cardiac-organoids 2024-10-18T10:48:25+02:00 0.5 https://www.ascenion.de/technologieangebote/ferulic-acid-derivatives-as-efficient-neuroprotective-agent-and-memory-enhancer 2024-12-06T14:49:36+01:00 0.5 https://www.ascenion.de/technologieangebote/wireless-miniature-microscope-for-near-field-image-capturing 2024-12-06T15:07:41+01:00 0.5 https://www.ascenion.de/technologieangebote/biomarker-panel-for-diagnosing-pulmonary-dysfunction 2025-02-26T13:31:43+01:00 0.5 https://www.ascenion.de/technologieangebote/tyrolian-algae-extract-with-anti-inflammatory-potential 2025-03-04T16:41:47+01:00 0.5 https://www.ascenion.de/technologieangebote/broadly-neutralizing-antibodies-against-hepatitis-e-virus-hev 2025-03-12T13:37:22+01:00 0.5 https://www.ascenion.de/technologieangebote/particle-mediated-transport-of-dissolved-active-agents-into-hair-follicles 2025-03-17T17:38:15+01:00 0.5 https://www.ascenion.de/technologieangebote/crispr-star-facilitating-high-resolution-genetic-screening-in-complex-in-vivo-models 2025-04-03T11:11:29+02:00 0.5 https://www.ascenion.de/technologieangebote/blood-based-tuberculosis-precision-medicine-transcriptomic-model-predicts-treatment-response 2025-04-03T16:27:17+02:00 0.5 https://www.ascenion.de/technologieangebote/liver-function-imaging-of-the-functional-hepatic-reserve 2025-04-10T12:24:18+02:00 0.5 https://www.ascenion.de/technologieangebote/niche-car-t-nr2f6-immune-checkpoint-harnessing-to-enhance-car-t-efficacy 2025-04-15T11:07:41+02:00 0.5 https://www.ascenion.de/technologieangebote/engineered-immune-cells-to-specifically-eliminate-undesired-immune-responses 2025-05-23T14:16:08+02:00 0.5 https://www.ascenion.de/technologieangebote/efficient-adjuvant-free-mucosal-vaccination-via-iga-feedback-loop 2025-06-06T12:35:18+02:00 0.5 https://www.ascenion.de/technologieangebote/functionalized-nanoparticles-for-viral-clearance 2025-06-10T16:30:01+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-diagnostic-for-peripartum-cardiomyopathy-ppcm-in-pregnant-women 2025-06-12T12:41:34+02:00 0.5 https://www.ascenion.de/technologieangebote/cytotoxicity-assay-for-detecting-cellular-damage 2025-06-13T13:02:58+02:00 0.5 https://www.ascenion.de/technologieangebote/prediction-of-l-asparaginase-resistance-in-tumor-therapy 2025-06-13T16:50:15+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-therapy-for-treatment-of-alzheimers-disease 2025-06-25T19:21:56+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-gas-flow-system-for-high-throughput-determination-of-oxygen-dissociation-curves-odc 2025-07-15T15:34:34+02:00 0.5 https://www.ascenion.de/technologieangebote/the-physiological-breast-milk-proteins-s100a8-and-s100a9-promote-an-eubiotic-gut-state-in-infants 2025-07-23T11:58:44+02:00 0.5 https://www.ascenion.de/technologieangebote/bioartificial-vascular-grafts-based-on-a-highly-compacted-acellular-fibrin-matrix 2025-08-06T15:42:58+02:00 0.5 https://www.ascenion.de/technologieangebote/lifespan-predictor-reliable-deep-learning-tool-for-in-vivo-lifespan-prediction 2025-08-14T15:29:36+02:00 0.5 https://www.ascenion.de/technologieangebote/ls-coat-an-exceptionally-efficient-tumor-vaccination-approach 2025-09-08T12:30:22+02:00 0.5 https://www.ascenion.de/technologieangebote/best-in-classnbspp-aeruginosa-lasb-virulence-factor-inhibitors 2025-09-09T15:23:14+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-inhibitors-of-cytomegalovirus 2025-09-09T15:40:27+02:00 0.5 https://www.ascenion.de/technologieangebote/cyclic-di-nucleotides-as-adjuvants 2025-09-09T16:50:42+02:00 0.5 https://www.ascenion.de/technologieangebote/cyclic-di-amp-a-promising-adjuvant-for-neonatal-vaccines 2025-09-09T16:59:59+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-vaccine-vector-platform-for-safe-and-effective-immunization-using-a-replication-deficient-murine-cytomegalovirus-mcmv 2025-09-11T15:21:28+02:00 0.5 https://www.ascenion.de/technologieangebote/innovative-dota-linkers-for-bacterial-targeting 2025-09-16T12:40:49+02:00 0.5 https://www.ascenion.de/technologieangebote/increased-availability-and-efficacy-of-aminoglycosides 2025-09-16T12:45:28+02:00 0.5 https://www.ascenion.de/technologieangebote/crisprdetect-multiplexed-rna-detection-with-reprogrammed-tracrrnas 2025-09-16T12:50:39+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-lectin-targeting-therapeutics-and-diagnostics-for-pseudomonas-aeruginosa-infections 2025-09-16T12:56:04+02:00 0.5 https://www.ascenion.de/technologieangebote/overcoming-resistance-innovative-broad-spectrum-inhibitors-of-metallo-b-lactamases 2025-09-16T13:10:27+02:00 0.5 https://www.ascenion.de/technologieangebote/phytosphingosine-derivatives-as-adjuvants-in-immune-stimulation 2025-09-16T13:18:18+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-myxopyronin-analogues-and-myxopyronin-genecluster-for-mutasynthesis 2025-09-16T13:19:36+02:00 0.5 https://www.ascenion.de/technologieangebote/cystobactamids-novel-antibacterials-against-gram-negative-pathogens 2025-09-16T13:23:11+02:00 0.5 https://www.ascenion.de/technologieangebote/highly-active-chlorotonil-a-derivatives-for-the-treatment-of-malaria 2025-09-16T13:36:21+02:00 0.5 https://www.ascenion.de/technologieangebote/first-in-classnbsps-aureusnbspa-hemolysin-inhibitors-for-lung-and-skin-infectionsnbsp 2025-09-16T13:53:55+02:00 0.5 https://www.ascenion.de/technologieangebote/best-in-class-darobactin-derivate-against-gram-negative-bacteria 2025-09-16T13:56:25+02:00 0.5 https://www.ascenion.de/technologieangebote/decoli-gut-decolonization-of-multi-resistant-escherichia-coli 2025-09-16T14:04:25+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-aso-based-mrna-silencing-technology-for-phage-host-interaction-research 2025-09-16T14:06:37+02:00 0.5 https://www.ascenion.de/technologieangebote/biodynamers-enhance-drug-delivery 2025-09-16T14:09:14+02:00 0.5 https://www.ascenion.de/technologieangebote/prediction-for-targeting-efficiency-of-guide-rna-for-a-gene-of-interest-in-bacteria 2025-09-16T14:13:39+02:00 0.5 https://www.ascenion.de/technologieangebote/drug-dosage-optimization-based-on-machine-learning-and-mechanistic-modeling 2025-09-16T14:15:38+02:00 0.5 https://www.ascenion.de/technologieangebote/next-generation-probiotics 2025-09-16T14:19:37+02:00 0.5 https://www.ascenion.de/technologieangebote/inhibitors-of-energy-coupling-factor-ecf-transporters-against-gram-positive-pathogens 2025-09-16T14:22:02+02:00 0.5 https://www.ascenion.de/technologieangebote/thiourea-based-antibiotics-against-acinetobacter-baumannii 2025-09-16T14:24:02+02:00 0.5 https://www.ascenion.de/technologieangebote/consolidated-bioprocessing-of-complex-carbohydrates-to-d-erythro-isocitric-acid-using-a-fungus 2025-09-16T14:28:57+02:00 0.5 https://www.ascenion.de/technologieangebote/keanumycins-antifungal-and-amoebicidal-natural-compounds-for-agricultural-biocontrol 2025-09-16T14:31:00+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-treatment-of-pulmonary-arterial-hypertension-pah 2025-09-17T19:08:11+02:00 0.5 https://www.ascenion.de/technologieangebote/fap-targeted-dual-imaging-for-guided-cancer-surgery 2025-09-23T16:30:01+02:00 0.5 https://www.ascenion.de/technologieangebote/maintenance-of-regulatory-t-cell-phenotype-by-expression-of-il-2-fusion-protein 2025-09-24T15:48:01+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-cars-for-the-treatment-of-inflammatory-bowel-disease 2025-09-24T16:29:47+02:00 0.5 https://www.ascenion.de/technologieangebote/activity-enhanced-variant-of-hyperactive-sleeping-beauty-transposase-sb100x 2025-09-25T14:01:40+02:00 0.5 https://www.ascenion.de/technologieangebote/safer-sleeping-beauty-transposase-variants-with-improved-integration-profilesnbsp 2025-09-25T14:03:28+02:00 0.5 https://www.ascenion.de/technologieangebote/sleeping-beauty-transposase-variants-with-increased-safety-due-to-reduced-half-life 2025-09-25T14:04:57+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-cars-for-the-treatment-of-multiple-sclerosis-and-alzheimers-disease 2025-09-30T16:30:02+02:00 0.5 https://www.ascenion.de/technologieangebote/the-asgpr-car-a-liver-specific-chimeric-antigen-receptor 2025-09-30T16:30:02+02:00 0.5 https://www.ascenion.de/technologieangebote/an-engineered-serine-integrase-for-targeted-gene-transfer-in-human-cells 2025-10-20T11:35:27+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-therapy-approach-for-treatment-of-lung-fibrosis 2025-10-20T16:32:14+02:00 0.5 https://www.ascenion.de/technologieangebote/breaktag-novel-method-for-detection-of-ds-breaks-and-analysis-of-crispr-induced-on-and-off-target-effects 2025-10-20T16:50:06+02:00 0.5 https://www.ascenion.de/technologieangebote/inspect-intron-encoded-reporter-transcripts-for-minimally-invasive-monitoring-of-coding-and-non-coding-rnas 2025-10-20T17:02:46+02:00 0.5 https://www.ascenion.de/technologieangebote/non-invasive-and-high-throughput-monitoring-of-exon-specific-isoform-expression 2025-10-20T17:11:04+02:00 0.5 https://www.ascenion.de/technologieangebote/reprogramming-immune-cells-for-car-cell-based-therapies 2025-10-27T11:22:12+01:00 0.5 https://www.ascenion.de/technologieangebote/method-for-tuning-brain-network-models-for-the-implementation-of-brain-digital-twins 2025-10-27T13:53:52+01:00 0.5 https://www.ascenion.de/technologieangebote/method-for-direct-measurement-of-functional-avidity-of-t-cells 2025-10-30T11:05:27+01:00 0.5 https://www.ascenion.de/technologieangebote/efficient-generation-of-murine-brain-organoids-from-adult-neural-stem-cells 2025-11-04T12:54:17+01:00 0.5 https://www.ascenion.de/technologieangebote/oral-antimotilin-based-inhibitors-for-treating-helicobacter-pylorinbspinfections 2025-11-05T11:45:20+01:00 0.5 https://www.ascenion.de/technologieangebote/advancing-bioproduction-hdlbp-overexpression-enhances-protein-production-and-secretion 2025-11-27T10:42:29+01:00 0.5 https://www.ascenion.de/technologieangebote/spider-silkfibrin-implant-for-the-regeneration-of-injured-spinal-cord 2025-12-02T12:20:00+01:00 0.5 https://www.ascenion.de/technologieangebote/treating-dementia-and-other-brain-disorders-with-natural-glycans 2025-12-11T12:40:17+01:00 0.5 https://www.ascenion.de/technologieangebote/biomarker-set-for-early-and-non-invasive-diagnosis-and-differentiation-of-renal-cell-carcinomas 2026-01-05T15:07:59+01:00 0.5 https://www.ascenion.de/technologieangebote/advanced-tracer-compounds-for-enhanced-detection-of-cellular-structures 2026-01-18T16:47:45+01:00 0.5 https://www.ascenion.de/technologieangebote/effective-prevention-of-biofilm-associated-infections-on-dental-implants 2026-02-09T10:00:15+01:00 0.5 https://www.ascenion.de/technologieangebote/novel-labyrinthopeptins-as-anti-viral-agents 2026-02-19T14:46:56+01:00 0.5 https://www.ascenion.de/technologieangebote/rapid-detection-of-shiga-toxin-producing-ecoli-stecnbsp 2026-02-19T15:17:57+01:00 0.5 https://www.ascenion.de/technologieangebote/stable-gene-transfer-with-hyperactive-sleeping-beauty-transposase-sb100x 2026-02-19T15:38:12+01:00 0.5 https://www.ascenion.de/technologieangebote/ultra-thin-imaging-fiber-endoscope-using-a-diffuser-as-encoder-and-a-deep-neural-network-as-decoder 2026-02-19T16:07:16+01:00 0.5 https://www.ascenion.de/technologieangebote/fiber-membrane-oxygenator-with-minimized-priming-volume 2026-02-25T10:01:45+01:00 0.5 https://www.ascenion.de/technologieangebote/improved-sleeping-beauty-transposon-system-for-gene-therapy-sb100xpt4 2026-02-25T10:28:21+01:00 0.5 https://www.ascenion.de/technologieangebote/method-and-arrangement-for-identification-and-correction-of-optical-aberrations 2026-02-25T10:30:22+01:00 0.5 https://www.ascenion.de/technologieangebote/method-and-kit-for-early-detection-of-preeclampsia 2026-02-25T10:30:59+01:00 0.5 https://www.ascenion.de/technologieangebote/vsv-encoded-hcv-vaccines-that-induce-broadly-neutralising-antibodies-against-hepatitis-c 2026-02-25T14:22:06+01:00 0.5 https://www.ascenion.de/technologieangebote/programmable-rna-guided-enzymes-and-novel-orthogonal-substrates-for-crispr-diagnostics 2026-02-25T15:24:28+01:00 0.5 https://www.ascenion.de/technologieangebote/the-prognostic-umbilical-swab-a-rapid-molecular-risk-stratification-tool-for-neonatal-sepsis-and-brain-injury 2026-03-03T16:04:02+01:00 0.5 https://www.ascenion.de/technologieangebote/irradiation-device-and-method-for-optical-cochlear-implants-and-laser-surgery-sytems 2026-03-06T13:08:53+01:00 0.5 https://www.ascenion.de/technologieangebote/efficient-multiplex-cryo-embedding-method-for-cost-efficient-high-throughput-tissue-analysis 2026-03-11T12:34:19+01:00 0.5 https://www.ascenion.de/technologieangebote/green-rodenticide-use-of-a-grayanotoxin-based-agent-for-rodent-control 2026-04-14T15:20:01+02:00 0.5 https://www.ascenion.de/technologieangebote/genome-architecture-mapping-gam 2026-05-15T10:14:40+02:00 0.5 https://www.ascenion.de/technologieangebote/3d-seq-localizing-spatial-gene-expression-in-3-dimensions-on-single-cell-level 2026-05-15T10:17:39+02:00 0.5 https://www.ascenion.de/technologieangebote/flam-seq-genome-wide-full-length-mrna-and-polya-tail-sequencing 2026-05-15T10:19:04+02:00 0.5 https://www.ascenion.de/technologieangebote/a-titin-dsred-knock-in-mouse-model-to-study-cardiac-and-skeletal-muscle-disorders 2026-05-15T10:22:34+02:00 0.5 https://www.ascenion.de/technologieangebote/a-titin-egfp-knock-in-mouse-model-to-study-cardiac-and-skeletal-muscle-disorders 2026-05-15T10:23:44+02:00 0.5 https://www.ascenion.de/technologieangebote/plasma-cell-specific-antibodies-targeting-bcma-for-the-treatment-of-multiple-myeloma-and-autoimmune-diseases 2026-05-18T10:49:29+02:00 0.5 https://www.ascenion.de/technologieangebote/jagaricin-a-novel-antifungal-natural-compound 2026-05-19T09:45:28+02:00 0.5 https://www.ascenion.de/technologieangebote/homology-independent-genomic-sequence-replacement 2026-05-19T09:46:30+02:00 0.5 https://www.ascenion.de/technologieangebote/ai-based-method-and-tool-deepneo-for-intravascular-optical-coherence-tomography-image-analysis-of-coronary-artery-neointimal-tissue 2026-05-19T12:24:37+02:00 0.5 https://www.ascenion.de/technologieangebote/short-term-isotope-pulse-labeling-method-for-analyzing-metabolic-states-and-drug-targets-in-biological-samples 2026-07-07T09:22:43+02:00 0.5 https://www.ascenion.de/technologieangebote/identifying-cellular-states-and-fate-transitions-via-synthetic-locus-control-regions-slcrs 2026-07-07T09:23:19+02:00 0.5 https://www.ascenion.de/technologieangebote/human-tcr-constructs-for-adoptive-cell-therapy-of-cancer 2026-07-07T09:27:18+02:00 0.5 https://www.ascenion.de/technologieangebote/t-cell-therapy-of-myd88l265p-dependent-b-cell-lymphoma 2026-07-07T11:50:28+02:00 0.5 https://www.ascenion.de/technologieangebote/warpdemux-method-for-demultiplexing-of-rna-sequencing-data 2026-07-09T15:34:52+02:00 0.5 https://www.ascenion.de/technologieangebote/selective-inhibitors-of-genotoxic-stress-induced-ikknfkb-pathways-for-cancer-therapy 2026-07-15T14:50:05+02:00 0.5 https://www.ascenion.de/technologieangebote/self-organizing-human-2d-neuromuscular-junction-model-and-3d-neuromuscular-organoids 2026-07-15T14:51:00+02:00 0.5 https://www.ascenion.de/technologieangebote/uv-fit-increasing-metabolic-fitness-and-reducing-body-weight-without-fasting 2026-07-15T14:55:39+02:00 0.5 https://www.ascenion.de/technologieangebote/nutritional-compositions-for-treating-dysfunction-of-liver-fat-metabolism-vafd 2026-07-15T14:57:11+02:00 0.5 https://www.ascenion.de/technologieangebote/proteasomeid-quantitative-mapping-of-proteasome-interactomes-and-substrates-in-vitro-and-in-vivo 2026-07-15T15:19:01+02:00 0.5 https://www.ascenion.de/technologieangebote/dream-complex-inhibitors-for-treating-medical-conditions-induced-by-circadian-rhythm-disruption 2026-07-15T15:20:01+02:00 0.5 https://www.ascenion.de/technologieangebote/microrna-signature-indicates-risk-for-cognitive-decline 2026-07-15T15:21:02+02:00 0.5 https://www.ascenion.de/technologieangebote/a-scalable-and-highly-sensitive-assay-for-measuring-extracellular-nad-level-in-human-body-fluids 2026-07-15T15:23:34+02:00 0.5 https://www.ascenion.de/technologieangebote/immunosuppressant-resistance-in-anti-viral-t-cell-productsnbsp 2026-07-15T15:26:46+02:00 0.5 https://www.ascenion.de/technologieangebote/high-level-recombinant-adeno-associated-virus-production 2026-07-15T15:29:34+02:00 0.5 https://www.ascenion.de/technologieangebote/cd3-car-nk-92-cell-mediated-tcr-depletion 2026-07-15T15:30:26+02:00 0.5 https://www.ascenion.de/technologieangebote/method-for-assessing-out-of-specification-oos-car-t-cell-products-and-predicting-patient-response 2026-07-15T15:31:39+02:00 0.5 https://www.ascenion.de/technologieangebote/the-cxcr3alt-cxcl11-chemokine-system-for-therapeutic-use-in-solid-cancer 2026-07-15T15:32:39+02:00 0.5 https://www.ascenion.de/technologieangebote/hsv-signature-antibodies-predict-the-development-of-anti-nmda-receptor-encephalitis 2026-07-15T15:33:27+02:00 0.5 https://www.ascenion.de/technologieangebote/base-editing-enzymes-for-multiplex-editing-with-simultaneous-gene-knock-in-and-knock-out 2026-07-15T15:34:31+02:00 0.5 https://www.ascenion.de/technologieangebote/two-dimensional-redundant-dual-barcoding-for-ultra-high-throughput-error-resilient-nucleic-acid-analysis 2026-07-27T06:44:08+02:00 0.5 https://www.ascenion.de/technologieangebote/17beta-hsdcl 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/acp33-acidic-cluster-protein-33-ligand-of-cd4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/acta-purified-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/adenovirus-type-5-e1b-55-kda 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/adenovirus-type-5-e4orf3 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/adenovirus-type-5-l4-100-kda 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/activation-induced-cytidine-deaminase-aid 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ago-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ago-2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebna-3a 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/helt 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ink4a 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/april 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/april-phosphothreonin-224 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/blocking-fc-gamma-receptor-mouse-several-isotypes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/bop1-human-block-of-proliferation 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/borna-gp18 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/borna-p24 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/borna-p40 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/borna-p56 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/brd7-human-cellular 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/c-24 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cbf1-csl-suh-rbp-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ccr9 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cds-several-dog 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cds-several-dog-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd49c 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cellular-brd7-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/c-myc-n-term 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/c1q-c3-c4-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/c1q-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/canine-cd44 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd154-human-monkey 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd3-epsilon-chain 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd4-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd44-canine 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd8-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd83-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd96 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cd155 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cdc45-cell-division-cycle-45p 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/chicken-gtp-cyclohydrolase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/chicken-interferon-g 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/chicken-interferon-alpha 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/chimerin 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cng-channel-alpha3-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cng-channel-cone-type-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cyclodextrinase-klebsiella-oxytoca 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cytip 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cythohesin-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/cytomegalievirus-glycoprotein-gp40 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dll1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dutpase-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dead-box-protein-dp103 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dead-box-protein-dp103-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dna-pol-delta-p50-subunit 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dna-pol-delta-p125-subunit 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dog-c1q 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dog-several-cds 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dog-several-cds-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/dutpase-ebv 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/e1b-ap5-hnrpul1-ribonucleoprotein-hnrnp 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-bhrf1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-dutpase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-ebna1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-ebna2-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-ebna2-wwp-peptide 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-ebna2a-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-ebna2b-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-lmp1-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ebv-lmp2a-tp-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/edg 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/env-herv-k10 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/env-herv-k10-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/env-herv-k10-2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/epitopes-several-hiv-2-nef-protein 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/epsilon-chain-protein-kinase-c 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/fc-gamma-receptor-mouse-blocking-several-isotypes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/formin-related-protein-in-leukocytes-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/fitc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/flt-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/gag-protein-herv-k10 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/gtp-cyclohydrolase-murine 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/gtp-cyclohydrolase-chicken 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/gtp-cyclohydrolase-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/guanylate-binding-protein-gbp-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/h3x 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hcmv-us28 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/herv-k10-env 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/herv-k10-env-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/herv-k10-env-2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/herv-k10-gag-protein 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hhv8-minor-capsid-antigen-orf-26 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hhv8-majorcapsid-antigen-ofr-25 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hhv8m-dutpase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hhv8-kaposin 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/histone-h3-k27-dimethylated 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/histone-h4-k20-methylated 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hiv-2-nef-protein-several-epitopes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hmd-methanothermobacter 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hmd-methanothermobacter-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hsp72 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-cellular-brd7 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-cellular-usp7hausp 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-c1q 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-cd154-monkey 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-gtp-cyclohydrolase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-importin-a1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-importin-a3 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-importin-a4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-importin-a5 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-importin-a7 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-methyltrans-ferase-prmt2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-notch1-intracellular-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-notch3-intracellular 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-origin-recognition-complex-ocr1-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-origin-recognition-complex-ocr2-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-origin-recognition-complexocr3-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-origin-recognition-complex-ocr6-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-pax9-murine 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-primase-p58-p48 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-replication-protein-a-rpa32 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/human-replication-protein-a-rpa70 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/utp18-human-rrna-processing-factor 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hyperpolarization-activated-channel-hcn1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hyperpolarization-activated-channel-hcn2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hyperpolarization-activated-channel-hcn3 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/hyperpolarization-activated-channel-hcn4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/id-mouse-lymphoma 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/igg2c-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/interferon-alpha-chicken 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/isotypes-various-murine-cd45 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/isotypes-several-fc-gamma-receptor-mouse-blocking 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/jul-1c11 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/k20-methylated-histone-h4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/kaposin-hhv8 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/karyopherin-alpha2-rch1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/lambda-light-chain-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/lark 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/larkrbm4a 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/lcmv-gp44-klon-25 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-supernatant-eletro-elualed-bands 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-supernatant-complete 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-supernatant-electro-elualed-bands 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-supernatant-edgprfa 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-supernatant-edgprfa-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ly11-mouse-anti-mouse-cd5 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/listeria-monocytogenes-internalin-b-dhly-pfra-7973 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/lyt-1-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ly12-mouse-anti-mouse-cd5 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/m161ag 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mad1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mage11 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mbp-maltose-binding-protein-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/methanothermobacter-hmd 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/methanothermobacter-hmd-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/methyltransferase-prmt2-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/monkey-human-cd154 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/motifantibody-poly-de 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/motifantibody-poly-pro 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-anti-mbp-maltose-binding-protein 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-irs-2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-irs-2-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-lyt-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-several-isotypes-fc-gamma-receptor-blocking 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-c1q-c3-c4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-cd4 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-anti-mouse-cd5-ly11 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-anti-mouse-cd5-ly12 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-cd8 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-anti-trpe 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-lymphoma-ld 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-rmt1-rmt2-rmt5-anti-thy1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-thy12-spleen-cbl 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/mouse-thy12-spleen-akr 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/murine-cd45-various-isotypes 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/murine-gtp-cyclohydrolase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/murine-pax9-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ncam-ab-5a2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/nef-protein-several-epitopes-hiv-2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/notch1-intracellular-mouse-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/notch3-intracellular-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/n-term-c-myc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ocr1-human-origin-recognition-complex-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ocr2-human-origin-recognition-complex-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ocr3-human-origin-recognition-complex-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ocr6-human-origin-recognition-complex-hsorc 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pay-pc2-associated-q-rich-protein 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pax1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pax9-murine-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pcna 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pes1-human-pescadillo-rrna-processing-factor 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pf1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pf631 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pp32 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/pirin 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/primase-p58-p48-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/protein-kinase-c-epsilon-chain 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/protein-kinase-c-zeta-chain 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/protein-phosphatase-2a 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rat-anti-gst-synergistic-to-m-gst 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rat-lambda-light-chain 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rat-mbp-maltose-binding-protein 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rat-anti-trpe 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rat-igg2c 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rbm4a 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rbm4b 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rbm4b-1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rbp-cbf1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rch1-karyopherin-alpha2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/replication-protein-a-rpa32-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/replication-protein-a-rpa70-human 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/replication-protein-a-rpa14 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/ribonucleoprotein-hnrnp-e1b-ap5-hnrpul1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/risp 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rmt1-rmt2-rmt5-anti-thy1-mouse 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-non-phosporylated 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-ser2-p 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-ser5-p 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/rna-polymerase-ii-ctd-ser7-p 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/sepiapterin-reductase 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/sh2d1a-x-linked-lymphoproliferative-disease-xlp 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/tenascin-r 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/tmem59 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/transcription-cofactor-nc2-alpha 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/thy12-mouse-spleen-cbl 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/thy12-mouse-spleen-akr 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/traf1 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/traf2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/trpe-rat 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/us28-hcmv 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/usp7hausp-human-cellular 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/viii41-zbp-89 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/wdr12-wd-repeat-12-rrna-processing-factor 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/wwp-peptide-ebv-ebna2 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/yku70-yeast 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/zeta-chain-protein-kinase-c 2026-08-02T06:52:18+02:00 0.5 https://www.ascenion.de/technologieangebote/scon-artificial-intron-devoid-of-hypomorphic-target-gene-effects-for-one-step-generation-of-conditional-animal-models 2026-08-04T14:18:10+02:00 0.5 https://www.ascenion.de/technologieangebote/lncrna-lipcar-predicts-disease-progression-in-heart-failure-and-myocardial-infarction-patients 2026-08-10T15:37:49+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-diagnostic-marker-for-early-detection-of-bladder-cancer 2026-08-12T11:09:01+02:00 0.5 https://www.ascenion.de/technologieangebote/novel-treatment-for-sepis-in-newborns 2026-08-12T11:47:27+02:00 0.5 https://www.ascenion.de/technologieangebote/metax-cross-domain-metagenomic-profiling-technology 2026-08-12T12:12:30+02:00 0.5 https://www.ascenion.de/technologieangebote/aav-vector-variants-for-ocular-gene-delivery 2026-08-12T12:15:58+02:00 0.5 https://www.ascenion.de/technologieangebote/injection-tunnel-for-stress-reduced-handling-of-laboratory-mice 2026-08-12T12:30:33+02:00 0.5 https://www.ascenion.de/technologieangebote/a-novel-immuno-oncology-approach-for-induction-and-massive-amplification-of-antigen-specific-cytotoxic-cd8-t-cells 2026-08-12T12:31:06+02:00 0.5 https://www.ascenion.de/technologieangebote/broad-spectrum-antiviral-compounds-against-known-and-emerging-viruses 2026-08-12T12:31:35+02:00 0.5 https://www.ascenion.de/technologieangebote/gene-editing-of-the-proteinase-3-autoantigen-as-a-novel-treatment-for-anca-associated-vasculitis 2026-08-12T12:32:12+02:00 0.5 https://www.ascenion.de/technologieangebote/genetically-manipulated-cornea-for-transplantation 2026-08-14T12:40:33+02:00 0.5